NCT01344187View on ClinicalTrials.gov

Safety and Efficacy Study of Corneal Collagen Cross-Linking in Eyes With Keratoconus

PHASE3CompletedINTERVENTIONAL
Enrollment

236

Participants

Timeline

Start Date

July 31, 2012

Primary Completion Date

June 30, 2015

Study Completion Date

June 30, 2016

Conditions
Keratoconus
Interventions
DRUG

riboflavin solution

0.12% riboflavin ophthalmic solution

DRUG

placebo solution

0.0% riboflavin ophthalmic solution

DEVICE

KXL System

30 mW/cm2

Trial Locations (10)

29464

Medical University of South Carolina Storm Eye Institute, Magill Vision Center, Mt. Pleasant

30342

Emory Eye Center, Atlanta

33136

Bascolm Palmer Eye Institute, Miami

43082

Comprehensive Eye Care of Central Ohio, Westerville

57108

Vance Thompson Vision, Sioux Falls

68144

Kugler Vision, Omaha

84020

Hoopes Vision, Draper

92697

UC Irvine Department of Ophthalmology, Irvine

02451

Ophthalmic Consultants of Boston, Waltham

08540

Pinceton Eye Goup, Princeton

Sponsors
All Listed Sponsors
lead

Glaukos Corporation

INDUSTRY